Decode Q2 Loss Up 38 Percent on Revenue Decline, Higher R&D Costs | GenomeWeb
NEW YORK (GenomeWeb News) – Decode Genetics said today that second-quarter losses widened 38 percent on falling revenue and soaring research and development costs.
 
Receipts for the three months ended June 30 dropped 9 percent to $10.4 million from $11.4 million in the same quarter last year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.